Result Summary for 208136/016
| Protocol ID: | 208136/016 |
| Clinical Study ID: | 208136/016 (MeMuRu-OKA-016) |
| Official Title: | Study to assess immunogenicity and safety of two lots of GSK Bios’ live attenuated measles-mumps-rubella-varicella vaccine, at two different titres, given as a single injection to healthy children with GSK Bios’ measles-mumps-rubella vaccine as control group |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | Combined Measles, Mumps, Rubella, Varicella Vaccine |
| Trade/Product Name: | Priorix-Tetra;Priorix-Tetra |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
